SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin (Q39824683)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin |
scientific article |
Statements
1 reference
SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin (English)
1 reference
Ju-Hwa Kim
1 reference
Tae Hyung Kim
1 reference
Han Sung Kang
1 reference
Jungsil Ro
1 reference
Hyung Sik Kim
1 reference
Sungpil Yoon
1 reference
14 July 2009
1 reference
1 reference
387
1 reference
3
1 reference
450-455
1 reference
Identifiers
1 reference
1 reference